GH Stock Analysis: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$86.88
2.27 (2.68%)
▲
5d:
+2.26%
30d:
-7.48%
90d:
-15.63%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 29, 2026
29d
Smart Money Accumulation
GH is down 4.2% this week, but smart money is accumulating calls. Top strike: $95 2026-05-15 with 10 OI. Call ratio: 90% View Scanner →
Strength: 6.1/10
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: GH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $86.88, which is considered oversold relative to its 30-day fair value range of $85.24 to $98.75.
Technical Outlook: Technically, GH is in a downtrend. Immediate support is located at $82.39, while resistance sits at $90.28.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $130.64 (+54.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GH is in a downtrend. Immediate support is located at $82.39, while resistance sits at $90.28.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $130.64 (+54.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$85.24 -
$98.75
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 54.4% below Wall St target ($130.64)
Fair Price Analysis
30-Day Fair Range
$85.24 -
$98.75
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$82.39
Resistance Level
$90.28
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-136.42
Wall Street Target
$130.64
(+54.4%)
Revenue Growth (YoY)
39.4%
Profit Margin
-42.4%
Share & Embed Analysis
Last updated: March 30, 2026 10:26 AM ET
Data refreshes hourly during market hours. Next update: 11:26 AM
Data refreshes hourly during market hours. Next update: 11:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
1
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Brian Bell
SELL
3000 shares
2026-03-16
Medina Manuel Hidalgo
SELL
1300 shares
2026-03-06
Terilyn J Monroe
SELL
8571 shares
2026-01-21
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 58 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 58 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 60 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$236 | 58 HOLD |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
